Keynumbers for: Biotech-IgG

 12/31/20106/30/201112/31/20116/30/201212/31/20126/30/201312/31/20136/30/2014
Number of months that the report spans126126126126
Total revenue (MSEK)12.622.634.901.342.711.123.762.88
Earnings before interest and taxes (EBIT) (MSEK)-4.46-1.50-7.30-1.38-3.36-2.23-3.83-1.53
Pre tax profit (PTP) (MSEK)-4.46-1.66-7.42-1.38-3.35-2.23-3.83-1.53
Net Revenue (MSEK)-5.16-1.70-7.40-1.38-3.39-2.21-3.82-1.49
Earnings per share (SEK)-0.53-0.16-0.62-0.07-0.09-0.03-0.05-0.02
Dividend per share (SEK)--------
Owner's equity (MSEK)6.736.802.882.972.752.711.944.45
Fixed assets (MSEK)4.874.741.260.620.330.510.350.11
Intangible assets (MSEK)-3.850.610.550.290.230.170.10
Liquid assets (MSEK)4.35-2.853.223.363.023.046.10
Total shareholder equity and liabilities (MSEK)-8.584.123.843.693.533.386.31
Long time debts including distributions (MSEK)--0.11-0.030.01-0.01
Short term debt (MSEK)2.481.781.130.870.910.811.441.85
The share's par value (SEK)1.001.00.050.050.050.050.050.05
Cash flow for the period (MSEK)--0.65-0.590.220.55-0.29-0.682.93
Number of shares (in millions)-12 320 54814 631 98731 749 40872 717 87578 618 19481 739 68498 591 553
Average number of employees1111-333

  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se